BidaskClub upgraded shares of Stryker Corporation (NYSE:SYK) from a hold rating to a buy rating in a research note released on Thursday.

Several other equities analysts have also issued reports on SYK. Cowen and Company reaffirmed a buy rating and issued a $160.00 target price (up from $150.00) on shares of Stryker Corporation in a report on Sunday, July 30th. Oppenheimer Holdings, Inc. set a $148.00 price objective on Stryker Corporation and gave the company a hold rating in a report on Friday, July 28th. Citigroup Inc. increased their price objective on Stryker Corporation from $114.00 to $125.00 and gave the company a sell rating in a report on Friday, June 9th. Stifel Nicolaus increased their price objective on Stryker Corporation from $151.00 to $158.00 and gave the company a buy rating in a report on Friday, July 28th. Finally, Jefferies Group LLC reissued a hold rating and set a $132.00 price objective on shares of Stryker Corporation in a report on Friday, June 30th. Three analysts have rated the stock with a sell rating, seven have issued a hold rating and twelve have assigned a buy rating to the stock. The stock presently has an average rating of Hold and an average target price of $144.03.

Shares of Stryker Corporation (NYSE SYK) opened at 144.29 on Thursday. The firm has a market capitalization of $53.97 billion, a PE ratio of 32.21 and a beta of 0.80. The company’s 50-day moving average price is $144.61 and its 200 day moving average price is $136.38. Stryker Corporation has a 12-month low of $106.48 and a 12-month high of $148.84.

Stryker Corporation (NYSE:SYK) last released its earnings results on Thursday, July 27th. The medical technology company reported $1.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.51 by $0.02. The company had revenue of $3.01 billion during the quarter, compared to analyst estimates of $2.98 billion. Stryker Corporation had a return on equity of 24.26% and a net margin of 14.22%. Stryker Corporation’s quarterly revenue was up 6.1% on a year-over-year basis. During the same period in the prior year, the company posted $1.39 earnings per share. On average, equities analysts forecast that Stryker Corporation will post $6.50 earnings per share for the current year.

ILLEGAL ACTIVITY NOTICE: This news story was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this news story on another site, it was illegally copied and republished in violation of United States and international copyright legislation. The correct version of this news story can be viewed at https://www.thecerbatgem.com/2017/08/21/stryker-corporation-syk-upgraded-by-bidaskclub-to-buy.html.

The company also recently declared a quarterly dividend, which will be paid on Tuesday, October 31st. Shareholders of record on Friday, September 29th will be given a dividend of $0.425 per share. The ex-dividend date is Thursday, September 28th. This represents a $1.70 dividend on an annualized basis and a yield of 1.18%. Stryker Corporation’s payout ratio is 37.95%.

In other Stryker Corporation news, insider Lonny J. Carpenter sold 5,000 shares of the firm’s stock in a transaction dated Friday, August 4th. The stock was sold at an average price of $146.36, for a total transaction of $731,800.00. Following the sale, the insider now owns 88,207 shares in the company, valued at $12,909,976.52. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider David Floyd sold 19,305 shares of the firm’s stock in a transaction dated Wednesday, July 12th. The shares were sold at an average price of $144.56, for a total value of $2,790,730.80. The disclosure for this sale can be found here. Insiders have sold 32,810 shares of company stock worth $4,754,958 in the last 90 days. Company insiders own 7.40% of the company’s stock.

Large investors have recently added to or reduced their stakes in the stock. Bollard Group LLC boosted its position in shares of Stryker Corporation by 0.4% in the first quarter. Bollard Group LLC now owns 829 shares of the medical technology company’s stock worth $109,000 after buying an additional 3 shares during the period. Acrospire Investment Management LLC bought a new position in shares of Stryker Corporation during the second quarter worth about $111,000. Motco boosted its position in shares of Stryker Corporation by 50.7% in the second quarter. Motco now owns 826 shares of the medical technology company’s stock worth $115,000 after buying an additional 278 shares during the period. Baystate Wealth Management LLC boosted its position in shares of Stryker Corporation by 2.1% in the first quarter. Baystate Wealth Management LLC now owns 1,066 shares of the medical technology company’s stock worth $139,000 after buying an additional 22 shares during the period. Finally, Bruderman Asset Management LLC bought a new position in shares of Stryker Corporation during the second quarter worth about $150,000. Institutional investors and hedge funds own 73.79% of the company’s stock.

Stryker Corporation Company Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.

Analyst Recommendations for Stryker Corporation (NYSE:SYK)

Receive News & Stock Ratings for Stryker Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker Corporation and related stocks with our FREE daily email newsletter.